Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Clinical Chemistry - Finals, Lecture notes of Clinical chemistry

Clinical Chemistry enhances the students' understanding regarding the testing process of a chemicals and how to utilize the equipments in the laboratory and actual set-up.

Typology: Lecture notes

2022/2023

Available from 04/23/2024

jeremiah-reyes
jeremiah-reyes 🇵🇭

5 documents

1 / 11

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Non-Protein Nitrogen (NPN)
Clinical Chemistry 1
BS Medical Technology BSMT 3-3 | Prof. Eric E. Carpo
Compound
Approximate Plasma
Concentration
(% of Total NPN)
Approximate Urine
Concentration
(% of Excreted N)
Urea
45-50
86.0
Amino Acids
25
Uric Acid
10
1.7
Creatinine
5
4.5
Creatine
1-2
Ammonia
0.2
2.8
A. Blood Urea Nitrogen (BUN)
It is the major end product of protein &
amino acid catabolism
Highest NPN compound in the blood
45-50%
It is synthesized in the liver from CO&
ammonia from the deamination of amino
acids via the Kreb's-Henseleit cycle or
Ornithine cycle
Following its synthesis in the liver, it is
transported to the kidneys for excretion
It is freely filtered at the glomerulus but
reabsorbed substantially at the PCT & the
inner collecting duct
The concentration of urea in the plasma is
determined by renal function, protein
content of the diet & the rate of protein
catabolism
The concentration of urea is expressed
only by the nitrogen content of urea so to
get the concentration of urea from BUN,
urea= BUN x 2.14
Clinical significance:
to evaluate renal function
to assess hydration status
to determine nitrogen balance
to aid in the diagnosis of renal disease
(first metabolite to increase in renal
disease)
to determine adequacy of dialysis (easily
removed by dialysis)
Azotemia means elevated concentration of NPNs in
the blood.
Uremia is a clinical term that describes the
patient's signs & symptoms when symptomatic
end- stage renal failure is present.
Decreased BUN is due:
to low protein intake
severe vomiting & diarrhea
severe liver disease
pregnancy
BUN: Creatinine ratio is 10:1 - 20:1
Table 2. Classification & causes of azotemia
Classification
Causes
Pre-renal
refers to conditions
with reduced blood
flow to the kidneys
thereby reducing urine
output & causing
retention of waste
product
High BUN: Crea ratio
with normal plasma
creatinine
congestive heart
failure (CHF)
hemorrhage
shock
dehydration
high protein diet
increased protein
catabolism
Renal
indicates that the
kidneys itself are
dysfunctional
diseases of the renal
vessels, glomerulus,
tubules & renal
interstitium
acute & chronic renal
failure
acute
glomerulonephritis
1
pf3
pf4
pf5
pf8
pf9
pfa

Partial preview of the text

Download Clinical Chemistry - Finals and more Lecture notes Clinical chemistry in PDF only on Docsity!

Non-Protein Nitrogen (NPN)

Clinical Chemistry 1

BS Medical Technology BSMT 3-3 | Prof. Eric E. Carpo

Compound Approximate Plasma Concentration (% of Total NPN) Approximate Urine Concentration (% of Excreted N) Urea 45-50 86. Amino Acids 25 — Uric Acid 10 1. Creatinine 5 4. Creatine 1-2 — Ammonia 0.2 2. A. Blood Urea Nitrogen (BUN) ● It is the major end product of protein & amino acid catabolism ● Highest NPN compound in the blood 45-50% ● It is synthesized in the liver from CO₂ & ammonia from the deamination of amino acids via the Kreb's-Henseleit cycle or Ornithine cycle ● Following its synthesis in the liver, it is transported to the kidneys for excretion ● It is freely filtered at the glomerulus but reabsorbed substantially at the PCT & the inner collecting duct ● The concentration of urea in the plasma is determined by renal function, protein content of the diet & the rate of protein catabolism ● The concentration of urea is expressed only by the nitrogen content of urea so to get the concentration of urea from BUN, urea= BUN x 2. ● Clinical significance: ○ to evaluate renal function ○ to assess hydration status ○ to determine nitrogen balance ○ to aid in the diagnosis of renal disease (first metabolite to increase in renal disease) ○ to determine adequacy of dialysis (easily removed by dialysis) ● Azotemia means elevated concentration of NPNs in the blood. ● Uremia is a clinical term that describes the patient's signs & symptoms when symptomatic end- stage renal failure is present. ● Decreased BUN is due: ○ to low protein intake ○ severe vomiting & diarrhea ○ severe liver disease ○ pregnancy ● BUN: Creatinine ratio is 10:1 - 20: Table 2. Classification & causes of azotemia Classification Causes Pre-renal ● refers to conditions with reduced blood flow to the kidneys thereby reducing urine output & causing retention of waste product ● High BUN: Crea ratio with normal plasma creatinine ● congestive heart failure (CHF) ● hemorrhage ● shock ● dehydration ● high protein diet ● increased protein catabolism Renal ● indicates that the kidneys itself are dysfunctional ● diseases of the renal vessels, glomerulus, tubules & renal interstitium ● acute & chronic renal failure ● acute glomerulonephritis

Post-renal ● results from anatomic obstruction to urine flow out of the kidney ● high BUN: Crea ratio with high plasma creatinine ● kidney stones (nephrolithiasis) ● congenital anomaly ● inflammatory lesion ● neoplasm Blood Urea Nitrogen (BUN) Specimen requirements: ● non-fasting sample (serum, plasma & urine) ● citrate & fluoride inhibit urease ● avoid hemolyzed sample ● refrigeration is important for urine specimens to prevent bacterial decomposition I. Chemical Method (Direct Method) A. Diacetyl Monoxime Method ● uses ferrithiocyanate as color developer ● This reaction is known as Fearon's Reaction. II. Enzymatic Method (Kinetic/Indirect Method) A. Hydrolysis of urea by urease ● the ammonia produced is measured by various methods to calculate the concentration of urea in the original sample. ● NH, Measurement Methods:

1. by use of coupled enzyme method to measure the rate of disappearance of NADH to NAD read at 340 nm. ● used by many automated instruments, best as a kinetic measurement 2. by using the Berthelot reaction- Nessler **Reagent

  1. by using an indicator dye** ● used in automated systems, multilayer film reagents & dry reagent strips 4. by measuring the conductivity of ammonium ion-Conductometric ● conversion of unionized urea to NH+ 4 , & CO²- 3 , resulting in increased conductivity III. Reference Method ● Isotope Dilution Mass Spectrometry ○ Not used in clinical laboratory B. Uric Acid (Blood Uric Acid/BUA) ● The final breakdown of purine (adenine & guanine) metabolism in humans. ● It is formed from xanthine by the action of xanthine oxidase in the liver & intestine. ● It is freely filtered, partially reabsorbed & secreted in the renal tubules. ● It is a weak acid; at pH 7.4 & is relatively insoluble

95% exists as monosodium urate (MSU) but at concentrations >6.8 mg/dL the plasma is saturated thus precipitates in the tissues, MSU precipitates In acidic urine as uric acid crystals ● Derived from 3 sources: ○ catabolism of ingested nucleoproteins (dietary) ○ catabolism of endogenous nucleoproteins ○ direct transformation of endogenous purine nucleotides ● Clinical significance:Hyperuricemia is found in the following conditions: 1. Gout ● disease found primarily in men 30-50 y/o, post-menopausal women ● pain & inflammation of the joints cause by precipitation of MSU ● persons with gout are highly susceptible to nephrolithiasis ● in severe cases deposition of uric acid crystals & urates in tissues occur known as tophi, causing deformities 2. Increased nuclear metabolism ● occurs in patients on chemotherapy for proliferative diseases such as leukemia, lymphoma, multiple myeloma, polycythemia, hemolytic & megaloblastic anemia ● monitoring of blood uric acid levels is important to avoid nephrotoxicity 3. Chronic renal disease ● causes hyperuricemia because filtration & secretion are impaired 4. Enzyme deficiencies ● inherited disorders of

of creatine kinase (CK). Phosphocreatine provides a ready, rapid-source of energy. ● Creatinine is not reused in the body's metabolism, solely as a waste product & not easily removed by dialysis. ● It is commonly used to monitor renal function, an index of overall renal function. ● It is a measure of the completeness of 24-hour urine collection. ● It is used to evaluate fetal kidney maturity- as gestation progresses, more creatinine is excreted by the fetus into the amniotic fluid (2mg/dL). ● Clinical significance: ○ Increased in impaired renal function- severity & monitor progression of disease ○ used to measure sufficiency of renal function ○ chronic nephritis ○ congestive heart failure ● decreased in: ○ decreased muscle mass ○ severe liver diseases ○ pregnancy ○ Inadequate dietary protein Creatinine Specimen requirements: ● non-lasting sample (serum, plasma & urine) ● hemolyzed & icteric samples should be avoided ● lipemia yields erroneous results ● Urine should be refrigerated after collection or frozen if longer than 4 days is required I. Chemical Methods A. Jaffe reaction ● classic assay for serum & urine creatinine where creatinine reacts with picric acid in alkaline solution (NaOH) to form a red-orange complex with an absorbance at approximately 490-505 nm ● non-specific method ● ascorbic acid, glucose, protein & acetoacetate (a-ketoacids) give falsely elevated values ● bilirubin & hemoglobin give falsely decreased values. ● 2 general chemical Jaffe methods:

1. Jaffe reaction without adsorbent-Folin Wu Method ● sensitive but non-specific method ● uses protein-free filtrate 2. Jalle reaction with adsorbent- Lloyd or Fuller's Earth Method ● sensitive & specific method uses adsorbent: ○ Lloyd's - sodium aluminum silicate ○ Fuller's Eartn - aluminum magnesium silicate ● to remove interferences present in the specimen & elution techniques are then utilized to separate the creatinine from the adsorbent which is then made to react with the freshly prepared Jaffle reagent ● It is time consuming ● not routinely used B. Kinetic Jaffe Method ● serum is mixed with Jalfe reagent & the rate of change in absorbance is measured between 2 points (ex. after 20 seconds & after 80 seconds incubation) ● By measuring the rate of color formation in the "window" between these 2 sets of reactions, the color contributed by creatinine can be more accurately assessed. ● Although this method eliminates many interferences, a-ketoacids & cephalosphorins are still present to cause falsely increased levels. II. Enzymatic Methods A. Creatinase-Creatine Kinase Method ● read at 340 nm ● this requires large sample & lacks sensitivity thus not widely used B. Creatinase-HO, Method ● adapted for dry-chemistry ● potential to replace Jaffe method because it is more specific ● no interferences from acetoacetate or cephalosphorins

III. Reference Method ● Isotope Dilution Mass Spectrometry ○ not used in clinical laboratory D. Ammonia ● Formed by the deamination of amino acids during protein metabolism. ● It is removed from the circulation & converted to urea in the liver. ● Its production is not dependent on renal function but on liver function. ● Ammonia is neurotoxic & is associated with encephalopathy. ● Clinical significance: ○ prognostic indicator for hepatic failure ○ severe liver disease ○ Reye's syndrome (acute metabolic disorder of the liver) Methods

1. lon Selective Electrode ● diffusion of NH 3 , through selective membrane in NH 4 CI causes a pH change which is measured potentiometrically ● good accuracy & precision 2. Enzymatic method using Glutamate Dehydrogenase (GLDH) ● most common on automated instruments ● read at 340 nm 3. Spectrophotometic Table 1. Reference Ranges Analyte Male Female BUN Serum/Plasma 24-hr Urine 6 - 20 mg/dL (2.1 - 7.1 mmol/L) 12 - 20 mg/dL 6 - 20 mg/dL (2.1 - 7.1 mmol/L) BUA 3.5 - 7.2 mg/dL (0.21 - 0.43 mmol/L) 2.6 - 6.0 mg/dL (0.16 - 0.36 mmol/L) Creatinine Jaffe: 0.9 - 1.3 mg/dL (80-115 umol/L) Enzymatic: Jaffe: 0.6 - 1.1 mg/dL (53 - 97 umol/L) Enzymatic: 0.6 - 1.1 mg/dL (53 - 97 umol/L) 0.5 - 0.8 mg/dL (44 - 71 umol/L)

Beta 2-Macroglo bulin Plasma Proteins:

1. Prealbumin (Transthyretin) ● transthyretin & retinol-binding protein are transport proteins that migrate together ● acts as a transport mechanism for thyroid hormones ● migrates ahead of albumin on high resolution electrophoresis ● has half-life of only 2 days ● used as a marker for CSF ● DECREASE : indicates poor nutritional status ● INCREASE : alcoholism, chronic renal failure, steroid treatment, NSAID therapy, Hodgkin disease ● Reference value : 18-45 mg/dL (0.1-0.4 g/L) 2. Albumin ● small, globular protein that is present in highest concentration in plasma ● major protein component of most extravascular body fluids ● maintains colloidal osmotic pressure ● serves as indicator of nutritional status ● serves as reservoir of amino acids ● major transport protein carrier for free fatty acids, phospholipids, metallic ions, drugs, hormones & bilirubin ● INCREASE : Dehydration (Hemoconcentration) ● DECREASE : Acute Inflammation, Malnutrition, Liver disease- decreased synthesis, Renal disease- increased urinary loss; ex. nephrotic syndrome, GI disorders- peptic ulcer or colitis ● Reference value : 3.5-5.0 g/dL (35-55 g/L) 3. Alpha-1 antitrypsin (AAT) ● is a serpin (serine protease inhibitor); it neutralizes trypsin-like enzymes ● other serpins are alpha- antichymotrypsin, alpha-2 antiplasmin, anti-thrombin III, C1 inhibitor ● acute phase reactant ● it neutralizes the enzyme neutrophil elastase released by WBCs ● present in highest concentration of alpha-1 plasma proteins ● INCREASE : Inflammation, Pregnancy, Contraceptive Use ● DECREASE : Emphysema, Juvenile hepatic cirrhosis/AAT deficiency ● Reference valu e: 145-270 mg/dL 4. Alpha-1 Fetoprotein (AFP) ● one of the first α-2 globulins to appear in mammalian sera during development of the embryo & is the dominant serum protein in early embryonic life ● major protein in fetal serum, synthesized primarily by the yolk sac & liver ● AFP reappears in the adult serum during certain pathological states ● migrates between albumin & AAT on electrophoresis of fetal or newborn serum ● INCREASE : Spina bifida/Neural tube defects, Multiple fetuses, Fetal demise, Feto-maternal bleed, Incorrect estimation of fetal age, Hepatocellular carcinoma ● DECREASE : Fetal trisomy 18; Trisomy 21 5. Alpha-1 acid glycoprotein/orosmucoid (AAG) ● implicated in the formation of cell membrane ● negative charge in acid solutions ● binds & inactivates basic & lipophilic hormones, including progesterone & progesterone antagonist RU486; binds & reduces bioavailability of many drugs ● INCREASE : inflammatory disease, malignant neoplasms ● DECREASE : estrogens (from pregnancy & OCP) , nephrotic syndromes ● Reference value : 55-140 mg/dL 6. Alpha-1 anti-chymotrypsin ● migrates between the α1 & α2 zones ● serine protease inhibitor– inhibits cathepsin G, pancreatic elastase, mast cell chymase & chymotrypsin ● binds & inactivates PSA ● associated with the pathogenesis of Alzeimer’s disease- it is a vital component of the amyloid deposits found in persons with this disorder ● INCREASE : infection, malignancy, burns, AMI & Alzheimer’s disease ● DECREASE : liver disease ● Reference value : 30-60 mg/dL 7. Haptoglobin ● binds free hemoglobin ● it prevents loss of hemoglobin in the urine ● natural bacteriostatic agent for iron-requiring bacteria such as E.coli ● evaluates the degree of intravascular hemolysis ● INCREASE : corticosteroid hormones & many NSAIDs ● DECREASE : hemolysis, estrogens ● Reference value : 26-185 mg/dL 8. Ceruloplasmin ● copper-containing protein which also has peroxidase activity ● marker for Wilson’s disease ● INCREASE : inflammation, cancer, pregnancy

DECREASE : Wilson’s disease, malnutrition, malabsorption, Menke’s kinky hair syndrome ● Reference value : 150-240 mg/dL

9. Alpha-2 macroglobulin (AMG) ● major component of the alpha-2 band in the serum protein electrophoresis (SPE) ● inhibits proteases such as trypsin, pepsin & plasmin ● forms a complex with prostate-specific antigen (PSA) ● INCREASE : nephrotic syndrome, diabetes & liver disease, estrogen, children ● DECREASE : severe acute pancreatitis, advanced prostate carcinoma ● Reference value : 150-420 mg/dL 10. Hemopexin ● it binds the heme released by degradation of hemoglobin ● helps in early dx of hemolysis ● INCREASE : inflammation, diabetes mellitus, Duchenne Muscular Dystrophy & some malignancies ● DECREASE : hemolytic anemias ● Reference value : 50-115 mg/dL 11. Transferrin (Siderophilin) ● transports iron ● used for differential diagnosis of anemias ● INCREASED : Iron Deficiency Anemia (IDA) ● DECREASED : inflammation, liver disease, malnutrition ● Reference value: ○ Male ■ 215-365 mg/dL ○ Female ■ 250-380 mg/dL 12. Fibrinogen ● most abundant coagulation factor ● acute phase reactant- markedly increased in inflammatory process ● high levels in plasma may cause elevated ESR- by coating the cells & allowing them to sediment in faster clumps ● INCREASE : inflammatory disorders, pregnancy, Oral Contraceptive Pill ● DECREASE : coagulation ● Reference value : 200-400 mg/dL 13. Complement ● acts as an opsonin, facilitating phagocytosis & cytolysis ● acute phase reactant produced by the liver ● INCREASE : inflammation ● DECREASE : DIC, hemolysis, malnutrition 14. C-Reactive Protein (CRP) ● cardiac marker- used as an early warning test for persons at risk with coronary artery disease ● opsonin ● an inflammatory marker that appears to reflect the severity of CHD & may contribute to its pathogenesis ● used as a rapid test for presumptive diagnosis between bacterial infection vs. infection **15. Lipoproteins

  1. Immunoglobulins Miscellaneous Proteins:
  2. Myoglobin** ● found in skeletal & cardiac muscles ● transports & stores oxygen from Hgb to intracellular respiratory enzymes of contractile cells ● higher affinity for oxygen than does Hgb ● has small MW (18 kDa) thus leaks from damaged cells more easily ● potential nephrotoxin ● one of the early protein markers for MI: onset 1-3 hours, peak 5-12 hours, normalizes in 18-30 hours; marker for angina 2. Troponins- Troponin T , Troponin I & Troponin C ● complex of three proteins that bind to the thin filaments of cardiac muscles ● regulators of actin & myosin ● TnT, Tn I & TnC are found in cardiac & skeletal muscles ● Tn T & Tn I are undetectable in many healthy individuals ● they serve as the most marker for AMI ● their levels may elevate after AMI attack in the absence of CK-MB elevations a. Troponin T ● valuable for AMI diagnosis ● useful for the assessment of early & late AMI, also in renal & muscle diseases ● sensitive marker for unstable angina ● useful in monitoring effectiveness of thrombolytics ● it rises in 3-4 hours after MI, peak level is at 10-24 hours, return to normal in 7 days (but may remain elevated for 10-14 days) ● ≥1.5 ng/mL is suggestive of AMI b. Troponin I ● only found in the myocardium ● highly specific for AMI ● 13x more abundant in the myocardium than CK-MB on a weight basis

Principle : migration of charged particles in an electrical field (Proteins separated based on electric charge densities) ● The single most important clinical application is for the identification of monoclonal spike of immunoglobulins & differentiating them from polyclonal hypergammaglobulinemia ● Cellulose acetate/agarose gel (support media) ● After separation, protein fractions are immersed in acid solution then stained by dyes (e.g. Coomassie blue) ● The medium is placed in scanning densitometer which compute the area under the absorbance ● Albumin (fastest), alpha-1 (2nd), alpha-2 (3rd), beta (4th) & gamma (5th) ● Reference values for each fraction: ○ Albumin ■ 53-65% (3.5-5.0 g/dL) ○ Alpha- ■ 2.5-5% (0.1-0.3 g/dL) ○ Alpha- ■ 7-13% (0.6-1.0 g/dL) ○ Beta ■ 8-14% (0.7-1.1 g/dL) ○ Gamma ■ 12-22% (0.8-1.6 g/dL) ● Abnormal patterns: ○ Gamma spike ■ multiple myeloma ○ Beta-Gamma bridge ■ hepatic cirrhosis (“tau”) ○ Alpha-2 spike ■ nephrotic syndrome ○ Alpha-1 flat curve ■ juvenile cirrhosis (AAT deficiency) ○ Spikes at Alpha-1, Alpha-2 & Beta regions ■ inflammation ● Dyes used: ○ Bromphenol Blue ■ (for paper medium) ○ Ponceau S ■ (gel & acetate) ○ Amido Black ■ (gel & acetate) ○ Coomasie Brilliant Blue Fig. 1. Electrophoretic pattern of protein fractions.

6. Refractometry ● Based on the refractive index of solutes in serum ● Is an alternative to chemical analyses ● Not useful in the clinical laboratory 7. Turbidimetric or Nephelometric Methods ● Uses SSA or Trichloroacetic Acid ● Measurement depends on the formation of a uniform fine precipitate which scatters incident light in suspension (nephelometry) or block light (turbidimetry) 8. Salt Fractionation ● Globulins can be separated from ablumin by salting-out procedures using sodium salts ● Reagents : Sodium Sulfate Salt Albumin ● Concentration is inversely proportional to the severity of liver disease ● Plasma levels decline when severe hepatocellular disease lasts for more than 3 weeks ● Decreased serum albumin concentration may be due to decreased synthesis **Methods:

  1. Salt Precipitation** ● Globulins are precipitated, albumin in supernatant is quantitated by biuret reaction ● time consuming & labor intensive 2. Dye Binding Technique ● widely used method for albumin determination ● Uses only dyes or indicators that bind very tightly to albumin ● Ideally 100% of dye will be bound to albumin none to other fractions ● It is a dissociation-association technique influenced by temperature ● Serum is the sample of choice ● Heparin yields falsely high results bec. it enhances dye binding to albumin ● Binding should not be affected by small changes in ionic strength pH a. Bromcresol Green (BCG) ● most commonly used method ● sensitive; overestimates low albumin levels ● used extensively in automatic analyzers in parallel with Biuret reagent for TP b. Methyl Orange ● non-specific for albumin c. Hydroxyazobenzene Benzoic Acid (HABA)

● many interferences (salicylates, bilirubin) d. Bromcresol Purple (BCP) ● most sensitive & specific method, accurate ● gives overview of relative changes in different protein fractions Evaluation of Total Protein Concentration: Albumin-Globulin Ratio (A/G): Reference range : 1.1-1. ● clinically useful in evaluating TP concentrations ● Globulins are not measured but calculated from TP & albumin ● A/G ratio= Albumin TP-Albumin ● Decreased A/G ○ decreased albumin or increased globulins ● Increased A/G ○ decreased globulin synthesis & increased albumin (dehydration) Fig. 2. Sample abnormal serum protein electrophoresis patterns.